Short answer: Not reliably. A plant may look like a vernacular “Sativa” or “Indica” type yet have a cannabinoid profile that cannot be inferred from its appearance. A 2022 study of two high-cannabidiol breeding populations found that visual and morphological differences did not consistently distinguish CBD-dominant plants from intermediate CBD/THC plants.
The researchers compared two medical-cannabis breeding populations designated MX-CBD-11 and MX-CBD-707. They measured leaf morphology, plant growth, dry biomass, cannabinoid profiles, THCA synthase (THCAS) gene sequences, and photosynthetic traits.
MX-CBD-11 plants were generally taller, less branched, and had narrower leaflets. MX-CBD-707 plants were bushier and had wider leaflets. Those differences supported describing the populations as narrow-leaflet and wide-leaflet drug types—roughly corresponding to the vernacular labels “Sativa” and “Indica.” The chemical results, however, did not follow the visual labels.
Both populations were bred for high CBD, but each contained both Type II plants, with an intermediate CBD/THC relationship, and Type III plants, which were CBD dominant. Visually similar plants could have different cannabinoid profiles, while morphologically different plants could contain similar amounts of CBD and THC.
The authors therefore concluded that visual appearance, leaf measurements, and the photosynthetic characteristics tested could not determine chemotype in these populations. THCAS gene sequences separated the chemotypes more effectively, although published molecular markers tested in silico had low discriminatory power in these particular populations.
Forensic conclusions must match the method actually used. A photograph, field description, leaf shape, or informal strain label is not a quantitative cannabinoid analysis. If the legal or scientific issue is THC content, CBD dominance, or compliance with a concentration threshold, the relevant evidence is validated chemical testing performed on a representative sample with documented handling and measurement uncertainty.
The study also illustrates a broader classification problem: “Sativa” and “Indica” may describe visible growth patterns or commercial categories, but those labels do not necessarily establish a specific chemical exposure. That distinction matters when a case moves from identifying plant material to interpreting potency, product composition, or possible pharmacological effects.
This was not a survey of every cannabis cultivar. It examined two high-CBD breeding populations under the study conditions. The result should not be stretched into a claim that morphology is never informative for any botanical purpose. The narrower and defensible conclusion is that morphology alone did not reliably determine chemotype in the studied plants.
Source: Murovec J, Eržen JJ, Flajšman M, Vodnik D. PubMed record (PMID 35283868); full article DOI.